Impact of Opioids on Cellular Metabolism: Implications for Metabolic Pathways Involved in Cancer
Pharmaceutics · 29.08.2023 · 15 (9) · 2225
DOI: 10.3390/pharmaceutics15092225 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 29.08.2023. Verfasst von Doorsa Tarazi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Toronto, Toronto, ON M5G 1A8, Canada. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 269 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Curtis Joseph and Harold Groves Chair in Anesthesia and Pain Medicine.
Abstract (Originalsprache)
Opioid utilization for pain management is prevalent among cancer patients. There is significant evidence describing the many effects of opioids on cancer development. Despite the pivotal role of metabolic reprogramming in facilitating cancer growth and metastasis, the specific impact of opioids on crucial oncogenic metabolic pathways remains inadequately investigated. This review provides an understanding of the current research on opioid-mediated changes to cellular metabolic pathways crucial for oncogenesis, including glycolysis, the tricarboxylic acid cycle, glutaminolysis, and oxidative phosphorylation (OXPHOS). The existing literature suggests that opioids affect energy production pathways via increasing intracellular glucose levels, increasing the production of lactic acid, and reducing ATP levels through impediment of OXPHOS. Opioids modulate pathways involved in redox balance which may allow cancer cells to overcome ROS-mediated apoptotic signaling. The majority of studies have been conducted in healthy tissue with a predominant focus on neuronal cells. To comprehensively understand the impact of opioids on metabolic pathways critical to cancer progression, research must extend beyond healthy tissue and encompass patient-derived cancer tissue, allowing for a better understanding in the context of the metabolic reprogramming already undergone by cancer cells. The current literature is limited by a lack of direct experimentation exploring opioid-induced changes to cancer metabolism as they relate to tumor growth and patient outcome.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, University of Toronto, Toronto, ON M5G 1A8, Canada.
- Program in Molecular Medicine, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
- Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
- Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON M5G 1E2, Canada.
ORCID-Profile: Doorsa Tarazi, Jason T Maynes
Förderung
- Curtis Joseph and Harold Groves Chair in Anesthesia and Pain Medicine
Zitieren
APA
Tarazi, D., & Maynes, J. T. (2023). Impact of Opioids on Cellular Metabolism: Implications for Metabolic Pathways Involved in Cancer. Pharmaceutics, 15(9), 2225. https://doi.org/10.3390/pharmaceutics15092225
Vancouver
Tarazi D, Maynes JT. Impact of Opioids on Cellular Metabolism: Implications for Metabolic Pathways Involved in Cancer. Pharmaceutics. 2023;15(9):2225. doi:10.3390/pharmaceutics15092225
BibTeX
@article{Tarazi2023,
author = {Tarazi, Doorsa and Maynes, Jason T},
title = {Impact of Opioids on Cellular Metabolism: Implications for Metabolic Pathways Involved in Cancer},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {9},
pages = {2225},
doi = {10.3390/pharmaceutics15092225}
}
EUVIMED